Evidence map›Paper›PMID 25081530›Full record

ReviewAdvances in cancer research2014

Hyaluronan regulation of endothelial barrier function in cancer.

Patrick A Singleton

Open access · greenAbstract readReview
In one paragraph

Review in Advances in cancer research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. [Overwork induces vascular endothelial barrier dysfunction in mice].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2024
    Article
  4. Article
  5. Article
  6. Age related changes in hyaluronan expression leads to Meibomian gland dysfunction.Matrix biology : journal of the International Society for Matrix Biology · 2023
    Article
  7. Characterization of the Limbal Epithelial Stem Cell Niche.Investigative ophthalmology & visual science · 2023
    Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. PeriostinMolecular oncology · 2021
    Article
  17. Gene Editing by Extracellular Vesicles.International journal of molecular sciences · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Patrick A SingletonDepartment of Medicine, Section of Pulmonary and Critical Care, Chicago, Illinois, USA; Department of Anesthesia and Critical Care, The University of Chicago, Chicago, Illinois, USA. Electronic address: psinglet@medicine.bsd.uchicago.edu.
University of Chicago · US

Funding

Hyaluronan and CD44 are Novel Targets for Acute Lung injuryR01HL095723 · NHLBI · UNIVERSITY OF CHICAGO · PI SINGLETON, PATRICK A · 2009 to 2013
$1.9M
NHLBI NIH HHS R01 HL095723NHLBI NIH HHS R01-HL 095723
6 · The paper itself

Abstract

Vascular integrity or the maintenance of blood vessel continuity is a fundamental process regulated by endothelial cell-cell junctions. Defects in endothelial barrier function are an initiating factor in several disease processes including tumor angiogenesis and metastasis. The glycosaminoglycan, hyaluronan (HA), maintains vascular integrity through specific mechanisms including HA-binding protein signaling in caveolin-enriched microdomains, a subset of lipid rafts. Certain disease states, including cancer, increase enzymatic hyaluronidase activity and reactive oxygen species generation, which break down high molecular weight HA (HMW-HA) to low molecular weight fragments (LMW-HA). LMW-HA can activate specific HA-binding proteins during tumor progression to promote disruption of endothelial cell-cell contacts. In contrast, exogenous administration of HMW-HA promotes enhancement of vascular integrity. This review focuses on the roles of HA in regulating angiogenic and metastatic processes based on its size and the HA-binding proteins present. Further, potential therapeutic applications of HMW-HA in treating cancer are discussed.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsAntineoplastic AgentsCaveolinsDisease ProgressionEndotheliumGlycosaminoglycansHumansHyaluronan ReceptorsHyaluronic AcidMembrane MicrodomainsMolecular WeightNeoplasm MetastasisNeoplasmsNeovascularization, PathologicProtein Structure, TertiaryAntineoplastic AgentsCaveolinsGlycosaminoglycansHyaluronan ReceptorsHyaluronic AcidReactive Oxygen SpeciesCancer metastasisCaveolin-enriched microdomainCD44HABP2HyaluronidaseRHAMMTLR4Tumor angiogenesisTumor cell extravasationVascular integrity

Identifiers

PMID25081530
PMCPMC4470488
OpenAlexW2273512812

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.